Neumora Therapeutics, Inc. (NMRA) Tops Q2 EPS by 12c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/14/2026

1. DPZ
2. NVDA
3. BAC
4. DRS
5. GS
6. AVAV
7. ACI
8. UNH
9. ORCL
10. LQDA

Go back to Neumora Therapeutics, Inc. (NMRA) Tops Q2 EPS by 12c

Stifel on Neumora Therapeutics (NMRA): ' it's hard to have much conviction in the mechanism in MDD'

August 7, 2025 10:00 AM EDT

Stifel analyst Paul Matteis reiterated a Hold rating and $2.00 price target on Neumora Therapeutics (NASDAQ: NMRA).

The analyst comments "We remain Hold rated on NMRA following 2Q25 earnings. Following the KOASTAL-1 failure of navacaprant in MDD, management has taken steps to optimize the... More